Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-14 6:22 pm Sale | 13G | EDGEWISE THERAPEUTICS INC EWTX | EcoR1 Capital LLC | 1,250,385 1.300% | -2,242,809 (-64.21%) | View |
| 2024-11-14 4:31 pm Sale | 13G | EDGEWISE THERAPEUTICS INC EWTX | VIKING GLOBAL INVESTORS LP | 1,481,146 1.600% | -4,678,000 (-75.95%) | View |
| 2024-11-14 4:14 pm Purchase | 13G | EDGEWISE THERAPEUTICS INC EWTX | BAKER BROS. ADVISORS LP | 5,840,059 6.200% | 5,840,059 (New Position) | View |
| 2024-11-14 08:59 am Sale | 13G | EDGEWISE THERAPEUTICS INC EWTX | Flynn James E | 1,781,006 1.900% | -2,697,586 (-60.23%) | View |
| 2024-11-12 5:23 pm Unchanged | 13D | EDGEWISE THERAPEUTICS INC EWTX | ORBIMED ADVISORS LLC | 14,756,096 15.600% | 0 (Unchanged) | View |
| 2024-11-12 09:55 am Sale | 13G | EDGEWISE THERAPEUTICS INC EWTX | FMR LLC | 653,207 0.696% | -4,127,355 (-86.34%) | View |
| 2024-11-08 2:17 pm Unchanged | 13G | EDGEWISE THERAPEUTICS INC EWTX | BlackRock Inc. | 6,393,567 6.800% | 0 (Unchanged) | View |
| 2024-10-22 6:06 pm Purchase | 13G | EDGEWISE THERAPEUTICS INC EWTX | BlackRock Inc. | 6,393,567 6.800% | 6,393,567 (New Position) | View |
| 2024-09-23 9:20 pm Sale | 13D | EDGEWISE THERAPEUTICS INC EWTX | Novo Holdings A/S | 5,549,900 5.900% | -794,530 (-12.52%) | View |
| 2024-07-10 10:10 am Sale | 13G | EDGEWISE THERAPEUTICS INC EWTX | FMR LLC | 4,780,562 5.118% | -1,711,951 (-26.37%) | View |
| 2024-02-14 10:26 am Purchase | 13G | EDGEWISE THERAPEUTICS INC EWTX | VIKING GLOBAL INVESTORS LP | 6,159,146 9.700% | 1,750,000 (+39.69%) | View |
| 2024-02-14 08:43 am Sale | 13G | EDGEWISE THERAPEUTICS INC EWTX | Deep Track Capital LP | 2,537,176 4.000% | -837,218 (-24.81%) | View |
| 2024-02-09 09:03 am Sale | 13G | EDGEWISE THERAPEUTICS INC EWTX | FMR LLC | 6,492,513 10.230% | -2,096,716 (-24.41%) | View |
| 2024-02-07 5:09 pm Purchase | 13G | EDGEWISE THERAPEUTICS INC EWTX | BlackRock Inc. BLK | 3,505,199 4.100% | 198,089 (+5.99%) | View |
| 2024-02-02 3:57 pm Purchase | 13G | EDGEWISE THERAPEUTICS INC EWTX | BlackRock Inc. BLK | 3,307,110 5.200% | 3,307,110 (New Position) | View |
| 2024-02-01 5:28 pm Purchase | 13G | EDGEWISE THERAPEUTICS INC EWTX | Flynn James E | 4,478,592 5.250% | 545,455 (+13.87%) | View |
| 2024-01-29 4:30 pm Purchase | 13G | EDGEWISE THERAPEUTICS INC EWTX | RA CAPITAL MANAGEMENT L.P. | 8,909,091 9.600% | 8,909,091 (New Position) | View |
| 2024-01-25 4:26 pm Purchase | 13D | EDGEWISE THERAPEUTICS INC EWTX | Novo Holdings A/S | 6,344,430 7.400% | 272,727 (+4.49%) | View |
| 2024-01-25 4:25 pm Purchase | 13D | EDGEWISE THERAPEUTICS INC EWTX | ORBIMED ADVISORS LLC | 14,756,096 17.300% | 454,545 (+3.18%) | View |
| 2023-06-28 4:17 pm Unchanged | 13D | EDGEWISE THERAPEUTICS INC EWTX | Novo Holdings A/S | 6,071,703 9.600% | 0 (Unchanged) | View |